Skip to main content

Table 2 Provider types on index claims of patients with strictly- and broadly-defined homocystinuria (HCU)

From: Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison

 

Strictly-defined HCUa

Broadly-defined HCUb

N = 2450

N = 6613

Provider Types

 Cardiology

40 (1.6%)

129 (2.0%)

 Endocrinology

25 (1.0%)

51 (0.8%)

 Family medicine

898 (36.7%)

2483 (37.5%)

 Genetics

6 (0.2%)

9 (0.1%)

 Healthcare facility

262 (10.7%)

747 (11.3%)

 Hematology

79 (3.2%)

162 (2.4%)

 Internal medicine

525 (21.4%)

1378 (20.8%)

 Neurology

164 (6.7%)

327 (4.9%)

 Nurse or PA

79 (3.2%)

256 (3.9%)

 OB/GYN

42 (1.7%)

148 (2.2%)

 Oncology

68 (2.8%)

159 (2.4%)

 Pediatrics

19 (0.8%)

46 (0.7%)

 Psychiatry

10 (0.4%)

27 (0.4%)

 Surgery

28 (1.1%)

54 (0.8%)

 Unspecified MD

112 (4.6%)

312 (4.7%)

 Otherc

101 (4.1%)

344 (5.2%)

  1. a > 2 HCU diagnoses, including > 1 ICD-10 diagnosis; b > 1 ICD-10 HCU diagnosis; c Patients with > 1 claim with an HCU diagnosis code on their index date may be included in > 1 provider type category; HCU homocystinuria, MD Doctor of Medicine, OB/GYN obstetrician/gynecologist, PA physician’s assistant
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us